A systematic scoping review of research on Black participants in the National Drug Abuse Treatment Clinical Trials Network.
- 1 February 2020
- journal article
- review article
- Published by American Psychological Association (APA) in Psychology of Addictive Behaviors
- Vol. 34 (1) , 117-127
Abstract
Black individuals experience a disproportionate burden of substance-related disabilities and premature death relative to other racial/ethnic groups, highlighting the need for additional research. The National Drug Abuse Treatment Clinical Trials Network (CTN), a research platform for multisite behavioral, pharmacological, and integrated trials designed to evaluate the effectiveness of substance use treatments in community settings with diversified patient populations, provides a wealth of research knowledge on substance use. Although CTN trials have enrolled over 5,000 Black individuals since its inception in 2000, there has been no synthesis of the findings, discussion of the implications, or suggestions for future research for Black individuals. Members of the Minority Interest Group of the CTN conducted a scoping review of published research on Black participants in CTN trials. Studies were included if the sample was more than 75% Black and/or specific findings pertaining to Black participants were reported. The review yielded 50 articles, with studies that mostly focused on baseline characteristics, followed by substance use treatment outcomes, HIV/risky sex behaviors, retention, comorbid conditions and measurement issues. This review highlighted the importance of several issues that are critical to understanding and treating substance misuse among Black people, such as the characteristics of Black people entering treatment, measurement equivalence, and engaging/retaining adolescents and young adults in treatment. There is still a continued need to identify the most effective treatments for Black individuals who use substances. The CTN offers several untapped opportunities to further advance research on Black individuals who use substances (e.g., secondary analyses of publicly available data). (PsycINFO Database Record (c) 2020 APA, all rights reserved).Keywords
Funding Information
- National Institute on Drug Abuse (K23DA042130, T32DA019426)
- National Institute of Alcohol Abuse and Alcoholism (F31 AA023443)
This publication has 91 references indexed in Scilit:
- Brief strategic family therapy versus treatment as usual: Results of a multisite randomized trial for substance using adolescents.Journal of Consulting and Clinical Psychology, 2011
- Motivational enhancement therapy for African American substance users: A randomized clinical trial.Cultural Diversity & Ethnic Minority Psychology, 2011
- Using a latent variable approach to inform gender and racial/ethnic differences in cocaine dependence: A National Drug Abuse Treatment Clinical Trials Network studyJournal of Substance Abuse Treatment, 2010
- Study results from the Clinical Trials Network's first 10 years: Where do they lead?Journal of Substance Abuse Treatment, 2010
- Association of Race and Ethnicity With Withdrawal Symptoms, Attrition, Opioid Use, and Side-Effects During Buprenorphine TherapyJournal of Ethnicity in Substance Abuse, 2010
- Substance Use, Childhood Sexual Abuse, and Sexual Risk Behavior among Women in Methadone TreatmentThe American Journal of Drug and Alcohol Abuse, 2009
- Comparison between self-report and hair analysis of illicit drug use in a community sample of middle-aged menAddictive Behaviors, 2008
- Infrequent Illicit Methadone Use Among Stimulant‐Using Patients in Methadone Maintenance Treatment Programs: A National Drug Abuse Treatment Clinical Trials Network StudyThe American Journal on Addictions, 2008
- Serious adverse events in randomized psychosocial treatment studies: Safety or arbitrary edicts?Journal of Consulting and Clinical Psychology, 2008
- Effects of Integrated Trauma Treatment on Outcomes in a Racially/Ethnically Diverse Sample of Women in Urban Community-based Substance Abuse TreatmentJournal of Urban Health, 2007